Statistics and reproducibility Statistical analyses were conducted via the TriNetX platform, incorporating Java 11.0.16 (Apache Commons Math 3.6.1), R 4.0.2 (Hmisc1-1, Survival 3.2-3), and Python 3.7 (lifelines, matplotlib, numpy, pandas, scipy, statsmodels)
Additionally, tirzepatide is not recommended for patients with severe gastrointestinal disease, including severe gastroparesis
UNDERSTANDING YOUR OPTIONS TIER PLANS Tier Plans are our most popular option and provide approximately 810 weeks of medication
Whether your medication remains safe to use depends on specific factors including ambient temperature, exposure duration, and cumulative room temperature storage time
If you are experiencing significant nausea at a current dose, the answer is usually to stay at that dose for an additional four weeks rather than either decreasing or increasing
Metabolic dysfunction-associated steatotic liver disease (MASLD), previously referred to under the umbrella of non-alcoholic fatty liver disease (NAFLD), is now recognized as the most prevalent chronic liver disease condition globally, closely linked to the rising rates of obesity [1, 2]